ResearcherUniversity of Kansas Medical CenterNo recent work listed
Qi Chen
Matched on ORCID iD 0000-0001-7485-0428; OpenAlex author ID A5100340131. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 13
2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 1 paper
Papers 4
- Novel Compound C150 Inhibits Pancreatic Cancer Cell Epithelial-to-Mesenchymal Transition and Tumor Growth in Mice. Last author DOI 10.3389/fonc.2021.773350↗
- Vimentin-positive circulating tumor cells as a biomarker for diagnosis and treatment monitoring in patients with pancreatic cancer. Co-author DOI 10.1016/j.canlet.2019.03.009↗
- Extract of the Medicinal Plant Pao Pereira Inhibits Pancreatic Cancer Stem-Like Cell In Vitro and In Vivo. Last author DOI 10.1177/1534735418786027↗
- Targeting Epithelial-Mesenchymal Transition for Identification of Inhibitors for Pancreatic Cancer Cell Invasion and Tumor Spheres Formation. Last author DOI 10.1371/journal.pone.0164811↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ruochen Dong · 3 shared papers, 2016–2021 · strength 0.34
- Paper Novel Compound C150 Inhibits Pancreatic Cancer Cell Epithelial-to-Mesenchymal Transition and Tumor Growth in Mice. DOI 10.3389/fonc.2021.773350↗
- Paper Extract of the Medicinal Plant Pao Pereira Inhibits Pancreatic Cancer Stem-Like Cell In Vitro and In Vivo. DOI 10.1177/1534735418786027↗
- Paper Targeting Epithelial-Mesenchymal Transition for Identification of Inhibitors for Pancreatic Cancer Cell Invasion and Tu… DOI 10.1371/journal.pone.0164811↗
- Tao Wang · 2 shared papers, 2016–2021 · strength 0.21
- Paper Novel Compound C150 Inhibits Pancreatic Cancer Cell Epithelial-to-Mesenchymal Transition and Tumor Growth in Mice. DOI 10.3389/fonc.2021.773350↗
- Paper Targeting Epithelial-Mesenchymal Transition for Identification of Inhibitors for Pancreatic Cancer Cell Invasion and Tu… DOI 10.1371/journal.pone.0164811↗
- Xiang Li · 1 shared paper, 2019 · strength 0.08
- Tao Ma · 1 shared paper, 2019 · strength 0.08
- Jianying Lou · 1 shared paper, 2019 · strength 0.08
- Tao Wei · 1 shared paper, 2019 · strength 0.08
- Risheng Que · 1 shared paper, 2019 · strength 0.08
- Jiaqi Yang · 1 shared paper, 2019 · strength 0.08
- Lei Zheng · 1 shared paper, 2019 · strength 0.08
- Tingbo Liang · 1 shared paper, 2019 · strength 0.08
- Xueli Bai · 1 shared paper, 2019 · strength 0.08
- Kishore Polireddy · 1 shared paper, 2016 · strength 0.06
- Ping Chen · 1 shared paper, 2016 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.